Responses to toll-like receptor ligands in children living in areas where schistosome infections are endemic

Journal of Infectious Diseases

Volumn 189, Issue 6, 2004, Pages 1044-1051

  Van Der Kleij, Desiree ^a,b   Van Den Biggelaar, Anita H J ^a   Kruize, Yvonne C M ^a   Retra, Kim ^a,b   Fillie, Yvonne ^a   Schmitz, Marion ^b   Kremsner, Peter G ^c   Tielens, Aloysius G M ^b   Yazdanbakhsh, Maria ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; GLYCOLIPID; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PHOSPHATIDYLSERINE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDEMIC DISEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; MALE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SCHISTOSOMA; SCHISTOSOMIASIS; SCHOOL CHILD;

ADOLESCENT; CELL LINE; CHILD; CYTOKINES; FEMALE; GLYCOLIPIDS; HUMANS; LIGANDS; LIPOPOLYSACCHARIDES; MALE; MEMBRANE GLYCOPROTEINS; PHOSPHATIDYLSERINES; RECEPTORS, CELL SURFACE; SCHISTOSOMIASIS HAEMATOBIA; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 1642336428     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/382089     Document Type: Article

References (30)

1. Wynn TA, Cheever AW, Williams ME, et al. IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J Immunol 1998; 160:4473-80.
2. Boros DL. The role of cytokines in the formation of the schistosome egg granuloma. Immunobiology 1994; 191:441-50.
3. Muhlradt PF, Kiess M, Meyer H, Sussmuth R, Jung G. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J Exp Med 1997; 185:1951-8.
4. Noss EH, Pai RK, Sellati TJ, et al. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis. J Immunol 2001; 167:910-8.
5. Aliprantis AO, Yang RB, Mark MR, et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 1999; 285:736-9.
6. Le LQ, Kabarowski JH, Weng Z, et al. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 2001; 14:561-71.
7. Sharif S, Arreaza GA, Zucker P, et al. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat Med 2001; 7:1057-62.
8. van der Kleij D, van Remoortere A, Schuitemaker JH, et al. Triggering of innate immune responses by schistosome egg glycolipids and their carbohydrate epitope GalNAcβ1-4(Fucα1-2Fucα1-3)GlcNAc. J Infect Dis 2002; 185:531-9.
9. van der Kleij D, Latz E, Brouwers JF, et al. A novel host-parasite lipid cross-talk: schistosomal lyso-phosphatidylserine activates Toll-like receptor 2 and affects immune polarization. J Biol Chem 2002; 277:48122-9.
10. van der Kleij D, Tielens AG, Yazdanbakhsh M. Recognition of schistosome glycolipids by immunoglobulin E: possible role in immunity. Infect Immun 1999; 67:5946-50.
11. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Med Sci 1959; 37:911-7.
12. Rouser G, Kritchevsky G, Yamamoto A, Simon G, Galli C, Bauman AJ. Diethylaminoethyl and triethylaminoethyl cellulose column chromatographic procedures for phospholipids, glycolipids, and pigments. Methods Enzymol 1969; 14:272-317.
13. Shi X, Niimi S, Ohtani T, Machida S. Characterization of residues and sequences of the carbohydrate recognition domain required for cell surface localization and ligand binding of human lectin-like oxidized LDL receptor. J Cell Sci 2001; 114:1273-82.
14. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972; 14:397-400.
15. Medvedev AE, Henneke P, Schromm A, et al. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of toll-like receptors 2 or 4. J Immunol 2001; 167:2257-67.
16. Lehner MD, Morath S, Michelsen KS, Schumann RR, Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J Immunol 2001; 166:5161-7.
17. Sato S, Nomura F, Kawai T, et al. Synergy and cross-tolerance between Toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J Immunol 2000; 165:7096-101.
18. Melnem RF, LoVerde PT. Mechanism of interaction of Salmonella and Schistosoma species. Infect Immun 1984; 44:274-81.
19. Braun-Fahrlander C, Riedler J, Herz U, et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347:869-77.
20. + T cells. Nature 1994; 372:691-4.
21. Tailleux L, Schwartz O, Herrmann JL, et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 2003; 197:121-7.
22. Radolf JD, Arndt LL, Akins DR, et al. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J Immunol 1995; 154:2866-77.
23. Linehan SA, Martinez-Pomares L, Gordon S. Macrophage lectins in host defence. Microbes Infect 2000; 2:279-88.
24. Wang JH, Doyle M, Manning BJ, Di Wu Q, Blankson S, Redmond HP. Induction of bacterial lipoprotein tolerance is associated with suppression of toll-like receptor 2 expression. J Biol Chem 2002; 277:36068-75.
25. Lauener RP, Birchler T, Adamski J, et al. Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 2002; 360:465-6.
26. Kinjyo I, Hanada T, Inagaki-Ohara K, et al. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 2002; 17:583-91.
27. Dobrovolskaia MA, Medvedev AE, Thomas KE, et al. Induction of in vitro reprogramming by Toll-like receptor (TLR) 2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-κB signaling pathway components. J Immunol 2003; 170:508-19.
28. Kobayashi K, Hernandez LD, Galan JE, Janeway CA, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002; 110:191-202.
29. Sato S, Takeuchi O, Fujita T, Tomizawa H, Takeda K, Akira S. A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways. Int Immunol 2002; 14:783-91.
30. King CL, Medhat A, Malhotra I, et al. Cytokine control of parasite-specific anergy in human urinary schistosomiasis: IL-10 modulates lymphocyte reactivity. J Immunol 1996; 156:4715-21.